Jens Luehring - Net Worth and Insider Trading
Jens Luehring Net Worth
The estimated net worth of Jens Luehring is at least $8,855 dollars as of 2024-11-13. Jens Luehring is the Director, 10% Owner of Bellerophon Therapeutics Inc and owns about 239,312 shares of Bellerophon Therapeutics Inc (BLPH) stock worth over $8,855. Details can be seen in Jens Luehring's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jens Luehring has not made any transactions after 2016-12-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jens Luehring
Jens Luehring Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jens Luehring owns 1 companies in total, including Bellerophon Therapeutics Inc (BLPH) .
Click here to see the complete history of Jens Luehring’s form 4 insider trades.
Insider Ownership Summary of Jens Luehring
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BLPH | Bellerophon Therapeutics Inc | 2016-12-09 | director & 10 percent owner |
Jens Luehring Latest Holdings Summary
Jens Luehring currently owns a total of 1 stock. Jens Luehring owns 239,312 shares of Bellerophon Therapeutics Inc (BLPH) as of December 9, 2016, with a value of $8,855.
Latest Holdings of Jens Luehring
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BLPH | Bellerophon Therapeutics Inc | 2016-12-09 | 239,312 | 0.04 | 8,855 |
Holding Weightings of Jens Luehring
Jens Luehring Form 4 Trading Tracker
According to the SEC Form 4 filings, Jens Luehring has made a total of 0 transactions in Bellerophon Therapeutics Inc (BLPH) over the past 5 years. The most-recent trade in Bellerophon Therapeutics Inc is the acquisition of 1,333 shares on December 9, 2016, which cost Jens Luehring around $11,200.
Insider Trading History of Jens Luehring
- 1
Jens Luehring Trading Performance
GuruFocus tracks the stock performance after each of Jens Luehring's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jens Luehring is 187.5%. GuruFocus also compares Jens Luehring's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jens Luehring within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jens Luehring's insider trading performs compared to the benchmark.
Performance of Jens Luehring
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 8.93 | | | | | |
| Relative Return to S&P 500(%) | 8.52 | | | | | |
Jens Luehring Ownership Network
Ownership Network List of Jens Luehring
Ownership Network Relation of Jens Luehring
Jens Luehring Owned Company Details
What does Bellerophon Therapeutics Inc do?
Who are the key executives at Bellerophon Therapeutics Inc?
Jens Luehring is the director & 10 percent owner of Bellerophon Therapeutics Inc. Other key executives at Bellerophon Therapeutics Inc include 10 percent owner Puissance Life Science Opportunities Fund Vi , VP of Business Operations Parag Suresh Shah , and See Remarks Martin Dekker .
Bellerophon Therapeutics Inc (BLPH) Insider Trades Summary
Over the past 18 months, Jens Luehring made no insider transaction in Bellerophon Therapeutics Inc (BLPH). Other recent insider transactions involving Bellerophon Therapeutics Inc (BLPH) include a net sale of 694,421 shares made by Puissance Capital Fund (gp) Llc , a net sale of 1,076,841 shares made by Puissance Life Science Opportunities Fund Vi , and a net sale of 9,455 shares made by Bobae Kim .
In summary, during the past 3 months, insiders sold 0 shares of Bellerophon Therapeutics Inc (BLPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,780,717 shares of Bellerophon Therapeutics Inc (BLPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,780,717 shares.
Bellerophon Therapeutics Inc (BLPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Bellerophon Therapeutics Inc Insider Transactions
Jens Luehring Mailing Address
Above is the net worth, insider trading, and ownership report for Jens Luehring. You might contact Jens Luehring via mailing address: C/o Linde North America Inc., 575 Mountain Avenue, Murray Hill Nj 07974.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
